Healthcare TechnologyKane Biotech Publishes Real-World Data on revyve Wound GelKane Biotech Inc. (TSXV: KNE) has announced the publication of a peer-reviewed study evaluating its revyve Antimicrobial Wound Gel in patients with chronic and complex wounds. The prospective observational case…
FDA & Clinical TrialsIovance Reports 24.6% Response Rate in Lifileucel Lung-Cancer Trial
FDA & Clinical TrialsSELLAS Begins Final Analysis of Phase 3 REGAL AML Trial
FDA & Clinical TrialsCullinan Receives FDA Clearance for Velinotamig Trial
FDA & Clinical TrialsBeam Reports Initial BEAM-301 Base-Editing Data in GSDIa
FDA & Clinical TrialsFDA Lifts Clinical Hold on Arbutus AB-101 Program
FDA & Clinical TrialsCognition Aligns with FDA on Zervimesine Phase 3 Trial
FDA & Clinical TrialsFDA Clears Fresenius multiFiltratePRO for ICU Kidney Care
FDA & Clinical TrialsSun Pharma’s Unloxcyt Wins NCCN Nod in Locally Advanced Skin Cancer
PharmaceuticalsOptimi Health Completes MDMA Batch for Three Global PTSD Programs
FDA & Clinical TrialsWeekly Obesity Pills From Ascletis Face a Crowded Oral Field
FDA & Clinical Trials
Coverage of FDA decisions, drug approvals, trial results, regulatory updates, and major healthcare milestones affecting biotech companies.
View all →
Biotech Market News
Reporting on biotech stock activity, earnings, partnerships, financings, mergers, acquisitions, and market-moving developments.
View all →
Healthcare Technology
News and analysis covering medical technology, AI in healthcare, diagnostics, genomics, digital health, and emerging biotech innovation.
View all →
Pharmaceuticals
Coverage focused on drug development, treatments, vaccines, oncology, rare diseases, and advances in pharmaceutical research.
View all →
Industry & Research
Articles exploring scientific discoveries, biotechnology trends, academic research, manufacturing advances, and the broader biotech landscape.
View all →
